Page 86 - TD-3-4
P. 86

Tumor Discovery                                                  RNA-protein complexes deregulated in cancer



               2013;8(12):e84060.                                 Cancer. 2020;19:64.
               doi: 10.1371/journal.pone.0084060                  doi: 10.1186/s12943-020-01159-9
            22.  Ukmar-Godec T, Wegmann S, Zweckstetter M. Biomolecular   33.  Gibson BA, Doolittle LK, Schneider WG, Gerlich DW,
               condensation of the microtubule-associated protein tau.   Redding S, Rosen MK. Organization of chromatin by intrinsic
               Semin Cell Dev Biol. 2020;99:202-214.              and regulated phase separation. Cell. 2019;179:470-484.
               doi: 10.1016/j.semcdb.2019.06.007                  doi: 10.1016/j.cell.2019.08.037
            23.  Ukmar-Godec T, Hutten S, Grieshop MP, et al. Lysine/RNA-  34.  Nylund P, Garrido-Zabala B, Kalushkova A, Wiklund HJ. The
               interactions drive and regulate biomolecular condensation.   complex nature of lncRNA-mediated chromatin dynamics
               Nat Commun. 2019;10(1):2909.                       in multiple myeloma. Front Oncol. 2023;13:1303677.
               doi: 10.1038/s41467-019-10792-y                    doi: 10.3389/fonc.2023.1303677
            24.  Boyko S, Surewicz WK. Tau liquid-liquid phase   35.  Hu WL, Jin L, Xu A, et al. GUARDIN is a p53-responsive
               separation in neurodegenerative diseases. Trends Cell Biol.   long noncoding RNA that is essential for genomic stability.
               2022;32(7):611-623.                                Nat Cell Biol. 2018;20:492-502.
               doi: 10.1016/j.tcb.2022.01.011                     doi: 10.1038/s41556-018-0066-7
            25.  Abasi LS, Elathram N, Movva M, Deep A, Corbett KD,   36.  Kurup JT, Kidder BL. Identification of H4K20 me3-and
               Debelouchina GT. Phosphorylation regulates tau’s phase   H3K4 me3-associated RNAs using CARIP-Seq expands the
               separation behavior and interactions with chromatin.   transcriptional and epigenetic networks of embryonic stem
               Commun Biol. 2024;7(1):251.                        cells. J Biol Chem. 2018;293(39):15120-15135.
               doi: 10.1038/s42003-024-05920-4                    doi: 10.1074/jbc.RA118.004974
            26.  Parolini F, Tira R, Barracchia CG, et al. Ubiquitination of   37.  Agredo A, Kasinski AL. Histone 4 lysine 20 tri-methylation:
               Alzheimer’s-related tau protein affects the liquid-liquid   A  key epigenetic regulator of chromatin structure and
               phase separation in a site- and cofactor-dependent manner.   disease. Front Genet. 2023;14:1243395.
               Int J Biol Macromol. 2022;201:173-181.
                                                                  doi: 10.3389/fgene.2023.1243395
               doi: 10.1016/j.ijbiomac.2021.12.191
                                                               38.  Fan L, Sun W, Lyu Y, et al. Chrom-seq identifies RNAs at
            27.  Farooqi AA, Fayyaz S, Poltronieri P, Calin G, Mallardo M.   chromatin marks. Sci Adv. 2024;10(31):eadn1397.
               Epigenetic deregulation in cancer: Enzyme players and      doi: 10.1126/sciadv.adn1397
               noncoding RNAs. Semin Cancer Biol. 2022;83:197-207.
                                                               39.  Ahmad A, Poltronieri P, Uddin S. Editorial: LncRNAs in
               doi: 10.1016/j.semcancer.2020.07.013
                                                                  cancer metastasis and therapy resistance.  Front  Oncol.
            28.  Mattick  JS,  Amaral  PP,  Carninci  P,  et al.  Long   2021;11:813274.
               noncoding RNAs: Definitions, functions, challenges and      doi: 10.3389/fonc.2021.813274
               recommendations. Nat Rev Mol Cell Biol. 2023;24:430-447.
                                                               40.  Zang C, Nie FQ, Wang Q,  et  al. Long noncoding RNA
               doi: 10.1038/s41580-022-00566-8
                                                                  LINC01133  represses  KLF2,  P21  and  E-cadherin
            29.  Poltronieri P. Regulatory RNAs: Role as scaffolds assembling   transcription through binding with EZH2 and LSD1 in non-
               protein complexes and their epigenetic deregulation. Explor   small cell lung cancer. Oncotarget. 2016;7:11696-11707.
               Target Antitumor Ther. 2024;5(4):841-876.
                                                                  doi: 10.18632/oncotarget.7077
               doi: 10.37349/etat.2024.00252
                                                               41.  Kong Y, Hsieh CH, Alonso LC. ANRIL: A lncRNA at the
            30.  Cusenza VY, Tameni A, Neri A, Frazzi R. lncRNA epigenetics:   CDKN2A/B  locus  with  roles  in  cancer  and  metabolic
               The significance of m6A and m5C lncRNA modifications in   disease. Front Endocrinol (Lausanne). 2018;9:405.
               cancer. Front Oncol. 2023;13:1063636.
                                                                  doi: 10.3389/fendo.2018.00405
               doi: 10.3389/fonc.2023.1063636
                                                               42.  Lian Y, Yan C, Ding J, et al. A novel lncRNA, LL22NC03-
            31.  Bure  IV,  Nemtsova  MV,  Kuznetsova  EB.  Histone   N64E9.1,  represses  KLF2  transcription by  binding  with
               modifications and non-coding RNAs: Mutual epigenetic   EZH2 in colorectal cancer. Oncotarget. 2017;8:59435-59445.
               regulation and role in pathogenesis.  Int J Mol Sci.      doi: 10.18632/oncotarget.19738
               2022;23:5801.
                                                               43.  Quagliata L, Matter MS, Piscuoglio S,  et al. Long
               doi: 10.3390/ijms23105801
                                                                  noncoding RNA HOTTIP/HOXA13 expression is
            32.  Yang X, Liu M, Li M,  et  al. Epigenetic modulations of   associated with disease progression and predicts the
               noncoding RNA: A novel dimension of Cancer biology. Mol   outcome in hepatocellular carcinoma patients. Hepatology.


            Volume 3 Issue 4 (2024)                         27                                doi: 10.36922/td.4657
   81   82   83   84   85   86   87   88   89   90   91